March 29, 2024
Otsuka Pharmaceutical Co., Ltd.
Kyushu University
Kyoto University
National Hospital Organization Nagoya Medical Center
The Institute of Medical Science, The University of Tokyo
´ºÓêÖ±²¥app School of Medicine
Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo; hereinafter "Otsuka Pharmaceutical") announced today that it has filed an application for marketing approval in Japan for a gene panel test for hematologic malignancies. The test was co-designed by Otsuka Pharmaceutical and the National Cancer Center Japan (Location: Tokyo; hereinafter "National Cancer Center") and developed through a joint research consortium with the National Cancer Center, Kyushu University (Location: Fukuoka Prefecture), Kyoto University (Location: Kyoto Prefecture), the National Hospital Organization Nagoya Medical Center (Location: Aichi Prefecture), the Advanced Clinical Research Center at The Institute of Medical Science, The University of Tokyo (Location: Tokyo), and the ´ºÓêÖ±²¥app School of Medicine (Location: Tokyo).
Please see below for the full press release.